リクビス医薬品使用結果調査（日本）

基本情報

NCT ID

NCT02937831

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

6

治験依頼者名

Takeda

概要

The purpose of this survey is to understand the following items observed in the actual clinical use of RIXUBIS. 1. Unexpected adverse drug reactions 2. Occurrence of adverse drug reactions in the actual clinical use 3. Factors that may affect safety and effectiveness 4. Occurrence of Factor IX (FIX) inhibitor development in patients with coagulation FIX deficiency 5. Safety and effectiveness for hemophilia B patients who received routine prophylactic therapy, on-demand therapy and perioperative therapy

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)